Device-Detected Atrial Fibrillation After ARTESiA and NOAH-AFNET 6: From Episode Burden to Net Clinical Benefit.
Device-detected atrial high-rate episodes and subclinical atrial fibrillation occupy an intermediate state between an electronic signal and clinically documented atrial fibrillation. ARTESiA showed that apixaban reduced stroke or systemic embolism compared with aspirin while increasing major bleeding. NOAH-AFNET 6 foun...